HealthTech

CureFit Raises $2 Mn, Eyes EBITDA Profitability In FY26

Published

on

[ad_1]

SUMMARY

CureFit raised the funding from existing investor First Luxembourg SCA at a flat valuation of $1.6 Bn

CureFit CEO Naresh Krishnaswamy said that the startup is on track to achieve EBITDA profitability by the end of March 2026

CureFit, which is eyeing a public listing in 2026, saw its revenue grow over 30% in FY25 and loss decline by over 50%

IPO-bound fitness unicorn CureFit has raised about $2 Mn (INR 16.8 Cr) from existing investor First Luxembourg SCA at a flat valuation of $1.6 Bn. The homegrown brand was pegged…

[ad_2]

Source link

You must be logged in to post a comment Login

Leave a Reply

Cancel reply

Exit mobile version